Complete

Finding ways to detect oesophageal cancer sooner

Cancer types:

Oesophageal cancer

Project period:

Research institute:

University of Cambridge

Award amount:

£239,214

Location:

United Kingdom

Maria Alcolea Headshot
Researcher Dr Maria Alcolea

Dr Maria Alcolea aims to identify biomarkers for oesophageal cancer that could be used to detect the disease early. 

Meet the scientist

Dr Maria Alcolea is a Principle Investigator in the Wellcome - MRC Cambridge Stem Cell Institute at the University of Cambridge. After receiving her PhD in 2007 she gained experience in cancer and stem cell biology at Bart's Cancer Institute in London and the Hutchinson/MRC Research Centre before starting her own group in 2015. 

Maria Alcolea Team
The science

There are around half a million people diagnosed worldwide each year with oesophageal cancer. Survival rates have seen little improvement over decades of research and today only around 1 in 8 people will survive for 10 years or more following diagnosis. One of the main reasons for the high mortality from oesophageal cancer is that the disease is often diagnosed at an advanced stage. 

Dr Maria Alcolea at the University of Cambridge, England, wants to uncover new ways to diagnose oesophageal cancer early, when the patient has the best chance of survival. To do this, her team are studying the molecular processes that occur as oesophageal cancer develops. Through this work, they hope to identify molecular markers that can be used to detect oesophageal cancer as early as possible. 

We are extremely grateful to generous supporters that keep on contributing to charities like Worldwide Cancer Research. These days, when austerity has impacted so much in science, it is encouraging to have faithful supporters that believe in what science can provide to society. This long-term investment in pioneering projects is essential in order to improve the outcome of cancer and most importantly to benefit the quality of life of patients suffering from this devastating disease. 

Maria Alcolea Headshot
Dr Maria Alcolea

Related projects

Maria Alcolea Team

Active United Kingdom

Oesophageal cancer

How do mutations interact to cause oesophageal cancer?

By better understanding how oesophageal cancer first emerges researchers hope to find new ways to prevent this disease and improve survival rates. 

Researcher: Dr Maria Alcolea

Understanding the role of mutation interactions in oesophageal cancer

Complete Germany

Oesophageal cancer

Can we unravel the genetic background of oesophageal cancer?

By comparing oesophageal cancer cells to healthy cells researchers hope to find clues towards much needed new treatments and improve the poor survival rates.

Researcher: Dr Denes Hnisz

Unravelling the genetic background of oesophageal cancer
Diana Blaydon and Team saying thanks

Active United Kingdom

Oesophageal cancer

How does the genetic disease tylosis cause oesophageal cancer?

Researchers hope to reveal ways to diagnose oesophageal cancer sooner and help treatments work better by better understanding the earliest stages of the disease.

Researcher: Dr Diana Blaydon

Revealing the earliest signs of oesophageal cancer
Share this page